Tomas Jose G. L.
- Country
- Spain
- Department
- Hematology
Research Overview
- A Multicenter, Randomized, Open-Label Study Comparing Romiplostim Plus Dexamethasone Versus Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia
- Phase II Multicentric Trial Evaluating Ibrutinib and Rituximab Efficacy and Safety in Indolent Mantle Cell Lymphoma
- Evaluation of the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Povetacicept in Patients with Autoimmune Cytopenias: An Open-Label Study
Data & Insights
Has run more than one trial at 49 of 111 partner sites.
Specializations
Immune Thrombocytopenia Management
The investigator specializes in treating chronic and primary immune thrombocytopenia (ITP), with particular focus on developing innovative therapeutic approaches for both newly diagnosed and persistent cases.
- Novel immunoglobulin therapies
- Treatment-resistant ITP cases
- Platelet response optimization
Clinical expertise extends to evaluating novel therapeutic agents for managing refractory and relapsed ITP conditions.
Autoimmune Cytopenia Treatment
Dedicated to advancing treatment options for various autoimmune cytopenias, including warm autoimmune hemolytic anemia (wAIHA) and cold agglutinin disease (CAD).
- Targeted immunological therapies
- Novel biological agents
- Subcutaneous treatment administration
Focuses on developing comprehensive treatment protocols for complex autoimmune blood disorders.
Therapeutic Innovation
Investigates cutting-edge treatments including BTK inhibitors and specialized immunological agents for blood disorders.
- Long-term treatment outcomes
- Combined therapy approaches
- Safety profile assessment
Emphasis on developing sustainable therapeutic solutions with reduced need for rescue therapy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.